CoChat

Advances in computational structure-based antibody design

Open access
Hummer, Alissa M., Abanades, Brennan, Deane, Charlotte M. · 2022 · Current Opinion in Structural Biology
Cited by 106

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Antibodies are currently the most important class of biotherapeutics and are used to treat numerous diseases. Recent advances in computational methods are ushering in a new era of antibody design, driven in part by accurate structure prediction. Previously, structure-based antibody design has been limited to a relatively small number of cases where accurate structures or models of both the target antigen and antibody were available. As we move towards a time where it is possible to accurately model most antibodies and antigens, and to reliably predict their binding site, there is vast potential for true computational antibody design. In this review, we describe the latest methods that promise to launch a paradigm shift towards entirely in silico structure-based antibody design.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.sbi.2022.102379

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 34

  1. Chiu, 2019, Antibody structure and function: the basis for engineering therapeutics, Antibodies, 8, 55, 10.3390/antib8040055 · DOI · Paper page
  2. Lu, 2020, Development of therapeutic antibodies for the treatment of diseases, J Biomed Sci, 27, 1, 10.1186/s12929-019-0592-z · DOI · Paper page
  3. Basu, 2019, Why recombinant antibodies — benefits and applications, Curr Opin Biotechnol, 60, 153, 10.1016/j.copbio.2019.01.012 · DOI
  4. Sormanni, 2018, Third generation antibody discovery methods:: in silico rational design, Chem Soc Rev, 47, 9137, 10.1039/C8CS00523K · DOI · Paper page
  5. Roy, 2017, In silico methods for design of biological therapeutics, Methods, 131, 33, 10.1016/j.ymeth.2017.09.008 · DOI
  6. Batool, 2019, A structure-based drug discovery paradigm, Int J Mol Sci, 20, 2783, 10.3390/ijms20112783 · DOI · Paper page
  7. Sliwoski, 2014, Computational methods in drug discovery, Pharmacol Rev, 66, 334, 10.1124/pr.112.007336 · DOI · Paper page
  8. Weigt, 2009, Identification of direct residue contacts in protein-protein interaction by message passing, Proc Natl Acad Sci U S A, 106, 67, 10.1073/pnas.0805923106 · DOI · Paper page
  9. AlQuraishi, 2021, Machine learning in protein structure prediction, Curr Opin Chem Biol, 65, 1, 10.1016/j.cbpa.2021.04.005 · DOI · Paper page
  10. Jones, 2022, The impact of AlphaFold2 one year on, Nat Methods, 19, 11, 10.1038/s41592-021-01365-3 · DOI · Paper page
  11. Ruffolo, 2020, Geometric potentials from deep learning improve prediction of CDR H3 loop structures, Bioinformatics, 36, I268, 10.1093/bioinformatics/btaa457 · DOI · Paper page
  12. da Silva, 2021, epitope3D: a machine learning method for conformational B-cell epitope prediction, Briefings Bioinf, 23, bbab423, 10.1093/bib/bbab423 · DOI · Paper page
  13. Pittala, 2020, Learning context-aware structural representations to predict antigen and antibody binding interfaces, Bioinformatics, 36, 3996, 10.1093/bioinformatics/btaa263 · DOI · Paper page
  14. Del Vecchio, 2021, Neural message passing for joint paratope-epitope prediction, arXiv
  15. Dai, 2021, Protein interaction interface region prediction by geometric deep learning, Bioinformatics, 37, 2580, 10.1093/bioinformatics/btab154 · DOI · Paper page
  16. Lensink, 2021, Prediction of protein assemblies, the next frontier: the CASP14-CAPRI experiment, Proteins Struct Funct Bioinforma, 89, 1800, 10.1002/prot.26222 · DOI · Paper page
  17. Guest, 2021, An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants, Structure, 29, 606, 10.1016/j.str.2021.01.005 · DOI
  18. Ambrosetti, 2020, Modeling antibody-antigen complexes by information-driven docking, Structure, 28, 119, 10.1016/j.str.2019.10.011 · DOI · Paper page
  19. Zacharias, 2010, Accounting for conformational changes during protein-protein docking, Curr Opin Struct Biol, 20, 180, 10.1016/j.sbi.2010.02.001 · DOI
  20. Raybould, 2021, Public Baseline and shared response structures support the theory of antibody repertoire functional commonality, PLoS Comput Biol, 17, 1, 10.1371/journal.pcbi.1008781 · DOI
  21. Myung, 2020, mCSM-AB2: guiding rational antibody design using graph-based signatures, Bioinformatics, 36, 1453, 10.1093/bioinformatics/btz779 · DOI
  22. Myung, 2021, mmCSM-AB: Guiding rational antibody engineering through multiple point mutations, Nucleic Acids Res, 48, W125, 10.1093/nar/gkaa389 · DOI
  23. Jin, 2021, Iterative refinement graph neural network for antibody sequence-structure Co-design, arXiv
  24. Eguchi, 2020, IG-VAE: generative modeling of immunoglobulin proteins by direct 3D coordinate generation, bioRxiv
  25. Leem, 2021, Deciphering the language of antibodies using self-supervised learning, bioRxiv
  26. Shuai, 2021, Generative language modeling for antibody design, bioRxiv
  27. Akbar, 2021, A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding, Cell Rep, 34, 108856, 10.1016/j.celrep.2021.108856 · DOI · Paper page
  28. Wu, 2020, A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2, Science, 368, 1274, 10.1126/science.abc2241 · DOI · Paper page
  29. Bullen, 2021, Cross-reactive SARS-CoV-2 neutralizing antibodies from deep mining of early patient responses, Front Immunol, 12, 678570, 10.3389/fimmu.2021.678570 · DOI
  30. Raybould, 2021, Current strategies for detecting functional convergence across B-cell receptor repertoires, mAbs, 13, 1996732, 10.1080/19420862.2021.1996732 · DOI
  31. Myung, 2021, CSM-AB : graph-based antibody–antigen binding affinity prediction and docking scoring function, Bioinformatics, 38, 1141, 10.1093/bioinformatics/btab762 · DOI
  32. Lees, 2017, Investigating substitutions in antibody-antigen complexes using molecular dynamics: a case study with broad-spectrum, influenza A antibodies, Front Immunol, 8, 143, 10.3389/fimmu.2017.00143 · DOI
  33. Cleves, 2021, Synergy and complementarity between focused machine learning and physics-based simulation in affinity prediction, J Chem Inf Model, 61, 5948, 10.1021/acs.jcim.1c01382 · DOI
  34. Schneider, 2022, SAbDab in the age of biotherapeutics: updates including SAbDab-nano, the nanobody structure tracker, Nucleic Acids Res, 50, D1368, 10.1093/nar/gkab1050 · DOI · Paper page

Cited by

See all 106

Metadata

Authors
Hummer, A. M., Abanades, B., & Deane, C. M.
Venue
Current Opinion in Structural Biology
Publisher
Elsevier BV
Published
2022-06
Volume
74
Pages
102379
ISSN
0959-440X (ISSN-L)
OpenAlex
W4225321559
Cited by
106
References
38
FWCI
4.76
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • Medical Research Council (MR/N013468/1)
  • Engineering and Physical Sciences Research Council
  • EPSRC Centre for Doctoral Training in Technology Enhanced Chemical Synthesis (EP/S024093/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.